Changes in airway inflammation and hyperresponsiveness after inhaled corticosteroid cessation in allergic asthma

International Archives of Allergy and Immunology

Volumn 152, Issue SUPPL. 1, 2010, Pages 41-46

  Takaku, Yotaro ^a   Nakagome, Kazuyuki ^a   Kobayashi, Takehito ^a   Yamaguchi, Takefumi ^a   Nishihara, Fuyumi ^a   Soma, Tomoyuki ^a   Hagiwara, Koichi ^a   Kanazawa, Minoru ^a   Nagata, Makoto ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Airway hyperresponsiveness; Asthma relapse; Dermatophagoides farinae; Eosinophils; House dust mites; Inhaled corticosteroids; Interleukin 4; Remission asthma

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; INTERLEUKIN 4; METHACHOLINE;

ADULT; AGED; ALLERGIC ASTHMA; BRONCHUS HYPERREACTIVITY; CLINICAL ARTICLE; CONFERENCE PAPER; DERMATOPHAGOIDES FARINAE; EOSINOPHIL COUNT; FEMALE; FOLLOW UP; HUMAN; INHALATION TEST; LOW DRUG DOSE; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RELAPSE; REMISSION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; SPUTUM ANALYSIS;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIGENS, DERMATOPHAGOIDES; ASTHMA; BRONCHIAL HYPERREACTIVITY; EOSINOPHILS; FEMALE; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; IMMUNOGLOBULIN E; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-4; LEUKOCYTE COUNT; MALE; MIDDLE AGED; RECURRENCE; SPUTUM; WITHHOLDING TREATMENT;

EID: 77953247163     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000312124     Document Type: Conference Paper

References (36)

1. Japanese Society of Allergy and Clinical Immunology: Japanese Pediatric Guidelines for the Treatment and Management of Asthma 2008. Tokyo, Kyowa Kikaku, 2008.
2. Vonk JM, Postma DS, Boezen HM, Grol MH, Schouten JP, Koëter GH, Gerritsen J: Childhood factors associated with asthma remission after 30 year follow up. Thorax 2004; 59: 925-929.
3. Sekerel BE, Civelek E, Karabulut E, Yildirim S, Tuncer A, Adalioglu G: Are risk factors of childhood asthma predicting disease persistence in early adulthood different in the developing world? Allergy 2006; 61: 869-877.
4. De Marco R, Locatelli F, Cerveri I, Bugiani M, Marinoni A, Giammanco G, Italian Study on Asthma in Young Adults Study Group: Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol 2002; 110: 228-235.
5. Grol MH, Postma DS, Vonk JM, Schouten JP, Rijcken B, Koëter GH, Gerritsen J: Risk factors from childhood to adulthood for bronchial responsiveness at age 32-42 yr. Am J Respir Crit Care Med 1999; 160: 150-156.
6. Toelle BG, Xuan W, Peat JK, Marks GB: Childhood factors that predict asthma in young adulthood. Eur Respir J 2004; 23: 66-70.
7. Visser MJ, Brand PL, Boezen HM, van Aalderen WM, Kauffman HF, Postma DS: Clinical and immunologic factors associated with the presence or absence of airways hyper- responsiveness in childhood asthma. Clin Exp Allergy 2002; 32: 1278-1284.
8. Taylor DR, Cowan JO, Greene JM, Willan AR, Sears MR: Asthma in remission. Can relapse in early adulthood be predicted at 18 years of age? Chest 2005; 127: 845-850.
9. Nagata S, Ago Y, Teshima H, Imada Y: Atopic disposition and bronchial reactivity to inhaled acetylcholine in young adults with a history of asthma in childhood. J Asthma 1984; 21: 151-159.
10. Illi S, von Mutius E, Lau S, Nickel R, Niggemann B, Sommerfeld C, Wahn U, Multicenter Allergy Study Group: The pattern of atopic sensitization is associated with the development of asthma in childhood. J Allergy Clin Immunol 2001; 108: 709-714.
11. Limb SL, Brown KC, Wood RA, Wise RA, Eggleston PA, Tonascia J, Hamilton RG, Adkinson NF Jr: Adult asthma severity in individuals with a history of childhood asthma. J Allergy Clin Immunol 2005; 115: 61-66. (Pubitemid 40075422)
12. Global Initiative for Asthma: Global Strategy for Asthma Management and Prevention 2008 (update). Bethesda, National Institutes of Health, 2008.
13. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA, Pedersen SE, GOAL Investigators Group: Can guidelinedefined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 2004; 170: 836-844.
14. American Thoracic Society: Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 1991; 144: 1202-1218.
15. Chai H, Farr RS, Froehlich LA, Mathison DA, McLean JA, Rosenthal RR, Sheffer AL, Spector SL, Townley RG: Standardization of bronchial inhalation challenge procedures. J Allergy Clin Immunol 1975; 56: 323-327.
16. Paggiaro PL, Dente FL, Morelli MC, Bancalari L, Di Franco A, Giannini D, Vagaggini B, Bacci E, Fabbri LM, Giuntini C: Postallergen inhaled budesonide reduces late asthmatic response and inhibits the associated increase of airway responsiveness to methacholine in asthmatics. Am J Respir Crit Care Med 1994; 149: 1447-1451.
17. Keatings VM, Evans DJ, O'Connor BJ, Barnes PJ: Cellular profiles in asthmatic airways: a comparison of induced sputum, bronchial washings, and bronchoalveolar lavage fluid. Thorax 1997; 52: 372-374.
18. Bacci E, Cianchetti S, Paggiaro PL, Carnevali S, Bancalari L, Dente FL, Di Franco A, Giannini D, Vagaggini B, Giuntini C: Comparison between hypertonic and isotonic saline- induced sputum in the evaluation of airway inflammation in subjects with moderate asthma. Clin Exp Allergy 1996; 26: 1395-1400.
19. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ: Sputum induction. Eur Respir J 2002; 37: 3s-8s.
20. Panhuysen CI, Vonk JM, Koëter GH, Schouten JP, van Altena R, Bleecker ER, Postma DS: Adult patients may outgrow their asthma: a 25-year follow-up study. Am J Respir Crit Care Med 1997; 155: 1267-1272. (Pubitemid 27172769)
21. Haahtela T, Järvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, Nikander K, Persson T, Selroos O, Sovijärvi A, Stenius-Aarniala B, Svahn T, Tammivaara R, Laitinen LA: Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma. N Engl J Med 1994; 331: 700-705.
22. Marabini A, Cardinalini G, Severini C, Ripandelli A, Siracusa A: Is normal bronchial responsiveness in asthmatics a reliable index for withdrawing inhaled corticosteroid treatment? Chest 1998; 113: 964-967.
23. Giannini D, Di Franco A, Cianchetti S, Bacci E, Dente FL, Vagaggini B, Paggiaro PL: Analysis of induced sputum before and after withdrawal or treatment with inhaled corticosteroids in asthmatic patients. Clin Exp Allergy 2000; 30: 1777-1784.
24. Waalkens HJ, Van Essen-Zandvliet EE, Hughes MD, Gerritsen J, Duiverman EJ, Knol K, Kerrebijn KF: Cessation of longterm treatment with inhaled corticosteroid (budesonide) in children with asthma results in deterioration. The Dutch CNSLD Study Group. Am Rev Respir Dis 1993; 148: 1252-1257.
25. van den Toorn LM, Overbeek SE, de Jongste JC, Leman K, Hoogsteden HC, Prins JB: Airway inflammation is present during clinical remission of atopic asthma. Am J Respir Crit Care Med 2001; 164: 2107-2113.
26. Bjerg-Bäcklund A, Perzanowski MS, Platts- Mills T, Sandström T, Lundbäck B, Rönmark E: Asthma during the primary school ages - prevalence, remission and the impact of allergic sensitization. Allergy 2006; 61: 549-555.
27. Sears MR, Greene JM, Willan AR, Wiecek EM, Taylor DR, Flannery EM, Cowan JO, Herbison GP, Silva PA, Poulton R: A longitudinal, population-based, cohort study of childhood asthma followed to adulthood. N Engl J Med 2003; 349: 1414-1422.
28. Sporik R, Holgate ST, Platts-Mills TA, Cogswell JJ: Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study. N Engl J Med 1990; 323: 502-507.
29. de Kluijver J, Evertse CE, Schrumpf JA, van der Veen H, Zwinderman AH, Hiemstra PS, Rabe KF, Sterk PJ: Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids. Am J Respir Crit Care Med 2002; 166: 294-300.
30. Gleich GJ: Mechanisms of eosinophil-associated inflammation. J Allergy Clin Immunol 2000; 105: 651-663.
31. Broide DH: Molecular and cellular mechanisms of allergic disease. J Allergy Clin Immunol 2001; 108:S65-S71.
32. Nagata M, Sedgwick JB, Bates ME, Kita H, Busse WW: Eosinophil adhesion to vascular cell adhesion molecule-1 activates superoxide anion generation. J Immunol 1995; 155: 2194-2202.
33. Masuyama K, Jacobson MR, Rak S, Meng Q, Sudderick RM, Kay AB, Lowhagen O, Hamid Q, Durham SR: Topical glucocorticosteroid (fluticasone propionate) inhibits cells expressing cytokine mRNA for interleukin-4 in the nasal mucosa in allergen-induced rhinitis. Immunology 1994; 82: 192-199.
34. To Y, Dohi M, Tanaka R, Sato A, Nakagome K, Yamamoto K: Early interleukin 4-dependent response can induce airway hyperreactivity before development of airway inflammation in a mouse model of asthma. Lab Invest 2001; 81: 1385-1396.
35. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, Wardlaw AJ, Pavord ID: Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002; 360: 1715-1721.
36. Deykin A, Lazarus SC, Fahy JV, Wechsler ME, Boushey HA, Chinchilli VM, Craig TJ, Dimango E, Kraft M, Leone F, Lemanske RF, Martin RJ, Pesola GR, Peters SP, Sorkness CA, Szefler SJ, Israel E, Asthma Clinical Research Network, National Heart, Lung, and Blood Institute/NIH: Sputum eosinophil counts predict asthma control after discontinuation of inhaled corticosteroids. J Allergy Clin Immunol 2005; 115: 720-727.